MAIA Biotechnology, Inc. (MAIA)
Largest Insider Buys in Sector
MAIA Stock Price History Chart
MAIA Stock Performance
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Insider Activity of MAIA Biotechnology, Inc.
Over the last 12 months, insiders at MAIA Biotechnology, Inc. have bought $869,024 and sold $0 worth of MAIA Biotechnology, Inc. stock.
On average, over the past 5 years, insiders at MAIA Biotechnology, Inc. have bought $1.54M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Smith Stan (director) — $499,409. Louie Ngar Yee (director) — $239,920. CHAOUKI STEVEN M (director) — $81,060.
The last purchase of 19,665 shares for transaction amount of $39,920 was made by Louie Ngar Yee (director) on 2024‑04‑25.
List of Insider Buy and Sell Transactions, MAIA Biotechnology, Inc.
| 2024-04-25 | director | 19,665 0.1191% | $2.03 | $39,920 | +17.54% | |||
| 2024-04-25 | director | 147,492 0.8932% | $2.03 | $299,409 | +17.54% | |||
| 2024-03-14 | director | 170,940 1.0953% | $1.17 | $200,000 | +124.43% | |||
| 2024-03-14 | director | 170,940 1.0953% | $1.17 | $200,000 | +124.43% | |||
| 2024-03-14 | director | 69,282 0.4439% | $1.17 | $81,060 | +124.43% | |||
| 2024-03-14 | director | 6,928 0.0444% | $1.17 | $8,106 | +124.43% | |||
| 2024-03-14 | director | 34,641 0.222% | $1.17 | $40,530 | +124.43% | |||
| 2023-05-18 | director | 1,200 0.0109% | $2.47 | $2,964 | -20.24% | |||
| 2023-05-15 | director | 3,000 0.0266% | $2.63 | $7,890 | -26.67% | |||
| 2023-04-28 | Chief Executive Officer | 4,000 0.037% | $2.50 | $10,000 | -20.33% | |||
| 2023-04-27 | director | 48,000 0.4117% | $2.25 | $108,000 | -17.57% | |||
| 2023-04-27 | director | 133,300 1.1432% | $2.25 | $299,925 | -17.57% | |||
| 2023-04-27 | director | 8,500 0.0729% | $2.25 | $19,125 | -17.57% | |||
| 2023-04-27 | Chief Financial Officer | 4,400 0.0377% | $2.25 | $9,900 | -17.57% | |||
| 2023-04-20 | director | 10,000 0.0965% | $3.74 | $37,400 | -44.19% | |||
| 2023-04-18 | director | 1,263 0.0128% | $4.17 | $5,267 | -47.34% | |||
| 2023-04-17 | director | 1,576 0.0139% | $3.69 | $5,815 | -47.64% | |||
| 2023-04-14 | director | 802 0.0073% | $3.58 | $2,871 | -44.44% | |||
| 2023-04-13 | director | 622 0.0057% | $3.62 | $2,252 | -44.32% | |||
| 2023-04-04 | Chief Executive Officer | 925 0.0085% | $3.56 | $3,293 | -42.73% |
Insider Historical Profitability
| Louie Ngar Yee | director | 1167189 4.8822% | $2.61 | 4 | 0 | <0.0001% |
| Smith Stan | director | 1005060 4.204% | $2.61 | 39 | 0 | <0.0001% |
| Luput Cristian | director | 367350 1.5366% | $2.61 | 17 | 0 | <0.0001% |
| Guerrero Ramiro | director | 319600 1.3368% | $2.61 | 15 | 0 | <0.0001% |
| CHAOUKI STEVEN M | director | 88891 0.3718% | $2.61 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $619,700.00 | 1.29 | 281,682 | +61.74% | +$236,550.45 | <0.0001 | |
| Centric Wealth Management | $196,890.00 | 0.31 | 67,198 | 0% | +$0 | 0.07 | |
| Geode Capital Management | $117,205.00 | 0.24 | 53,257 | +19.53% | +$19,146.47 | <0.0001 | |
| Bridgeway Capital Management | $100,540.00 | 0.21 | 45,700 | -39.63% | -$66,000.00 | <0.01 | |
| Virtu Financial Llc | $71,000.00 | 0.15 | 32,487 | New | +$71,000.00 | 0.01 |